Artificial protein reduces Alzheimer's risk
A Spanish research team has developed an artificial protein that reduces the production of beta-amyloid protein, the main cause of brain cell damage and the formation of Alzheimer's plaques. The strategy relied on carefully targeting the BACE1 enzyme without completely blocking its function, in order to avoid serious side effects caused by previous attempts. Experiments on nerve cells and mice with the disease have shown success in decreasing protein accumulation, enhancing the possibility of developing a safer and more effective treatment for Alzheimer's.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)